Stephanie Markovina, Ph.D.
Affiliations: | 2008 | University of Wisconsin, Madison, Madison, WI |
Area:
Cell BiologyGoogle:
"Stephanie Markovina"Parents
Sign in to add mentorShigeki Miyamoto | grad student | 2008 | UW Madison | |
(Proteasome inhibitor resistant NF -kappaB activity in multiple myeloma.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Wang S, Luke CJ, Pak SC, et al. (2022) SERPINB3 (SCCA1) inhibits cathepsin L and lysoptosis, protecting cervical cancer cells from chemoradiation. Communications Biology. 5: 46 |
Contreras J, Srivastava A, Chundury A, et al. (2020) Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society |
Wang S, Luke C, Shi V, et al. (2020) Abstract 2426: SERPINB3 promotes radiation resistance in cervical cancer by inhibiting lysosome-mediated cell death Cancer Research. 80: 2426-2426 |
Cosper PF, McNair C, González I, et al. (2019) Decreased Local Immune Response and Retained HPV Gene Expression during Chemoradiotherapy are Associated with Treatment Resistance and Death from Cervical Cancer. International Journal of Cancer |
Wisdom AJ, Hong CS, Lin AJ, et al. (2019) Neutrophils promote tumor resistance to radiation therapy. Proceedings of the National Academy of Sciences of the United States of America |
Lin AJ, Samson P, Zoberi J, et al. (2019) Concurrent chemoradiation for cervical cancer: Comparison of LDR and HDR brachytherapy. Brachytherapy |
Lin AJ, Ma S, Markovina S, et al. (2019) Clinical outcomes after isolated pelvic failure in cervical cancer patients treated with definitive radiation. Gynecologic Oncology |
Hassanzadeh C, Srivastava A, Markovina S, et al. (2019) Prognostic Significance of pl6 in Patients with Cervical Cancer Receiving Definitive Chemoradiation International Journal of Radiation Oncology*Biology*Physics. 103: E33 |
Huepenbecker S, Lange S, Chin R, et al. (2019) Fistula formation in cervical cancer patients treated with bevacizumab: Pharmacovigilance after GOG 240 Gynecologic Oncology. 154: 144-145 |
Lin AJ, Hassanzadeh C, Markovina S, et al. (2018) Brachytherapy and survival in small cell cancer of the cervix and uterus. Brachytherapy |